US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Valion Bio Inc

0.8800

-0.0509-5.47%

Post-market: 0.89000.0100+1.14%19:59 EDT

Volume:368.57K

Turnover:353.03K

Market Cap:2.76M

PE:-0.11

High:1.06

Open:0.9700

Low:0.8546

Close:0.9309

52wk High:5.60

52wk Low:0.7217

Shares:3.14M

Float Shares:2.78M

Volume Ratio:2.01

T/O Rate:13.27%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.6830

EPS(LYR):-19.6785

ROE:-82.69%

ROA:-28.69%

PB:0.16

PE(LYR):-0.04

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Valion Bio’s Velocity Bioworks licenses LarmorBio’s BioScan-NMR platform

Valion Bio Q1 net loss widens to $6.2 million

BRIEF-Valion Bio Reports First Quarter 2026 Financial Results

Valion Bio Q1 EPS $(2.23) Up From $(2.52) YoY

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VBIO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","market":"US","secType":"STK","nameCN":"Valion Bio Inc","latestPrice":0.88,"timestamp":1778875200000,"preClose":0.9309,"halted":0,"volume":368568,"hourTrading":{"tag":"盘后","latestPrice":0.89,"preClose":0.88,"latestTime":"19:59 EDT","volume":1869,"amount":1680.1068,"timestamp":1778889587805,"change":0.01,"changeRate":0.011364,"amplitude":0.051136},"delay":0,"changeRate":-0.054678268342464226,"floatShares":2777300,"shares":3139095,"eps":-7.683047,"marketStatus":"Market Closed","change":-0.0509,"latestTime":"05-15 16:00:00 EDT","open":0.97,"high":1.06,"low":0.8546,"amount":353034.4067856,"amplitude":0.220647,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.683047,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":0,"listingDate":1636606800000,"exchange":"NASDAQ","adjPreClose":0.9309,"preHourTrading":{"tag":"盘前","latestPrice":0.959,"preClose":0.9309,"latestTime":"09:20 EDT","volume":8956,"amount":8278.973866799999,"timestamp":1778851217872,"change":0.0281,"changeRate":0.030186,"amplitude":0.075196},"postHourTrading":{"tag":"盘后","latestPrice":0.89,"preClose":0.88,"latestTime":"19:59 EDT","volume":1869,"amount":1680.1068,"timestamp":1778889587805,"change":0.01,"changeRate":0.011364,"amplitude":0.051136},"volumeRatio":2.009379269875749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VBIO\",,,,,undefined,":{"symbol":"VBIO","floatShares":2777300,"roa":"-28.69%","roe":"-82.69%","lyrEps":-19.678463,"volumeRatio":2.009379269875749,"shares":3139095,"dividePrice":0,"high":1.06,"amplitude":0.220647,"preClose":0.9309,"low":0.8546,"week52Low":0.721683,"pbRate":"0.16","week52High":5.6,"institutionHeld":0,"latestPrice":0.88,"eps":-7.683047,"divideRate":0,"volume":368568,"delay":0,"ttmEps":-7.683047,"open":0.97,"prevYearClose":1.45,"prevWeekClose":0.96,"prevMonthClose":0.9798,"prevQuarterClose":0.8858,"fiveDayClose":0.96,"twentyDayClose":1.26,"sixtyDayClose":0.8153},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VBIO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VBIO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VBIO","date":"2026-05-15","current":-0.114538,"percent":0.636364,"low":-0.392475,"twenty":-0.341701,"median":-0.33551,"eighty":-0.327405,"high":-0.298231,"avg":-0.338856,"sd":0.026132,"marketCap":2922183},"quantilePoints":[{"date":"2026-04-30","current":-0.311197,"twenty":-0.324163,"median":-0.319301,"eighty":-0.314439,"marketCap":2762808},{"date":"2026-05-08","current":-0.33713,"twenty":-0.336482,"median":-0.327405,"eighty":-0.314439,"marketCap":2993043},{"date":"2026-05-15","current":-0.329149,"twenty":-0.341701,"median":-0.33551,"eighty":-0.327405,"marketCap":2922183}],"updateTime":1778975421592},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VBIO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635273724","title":"Valion Bio’s Velocity Bioworks licenses LarmorBio’s BioScan-NMR platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2635273724","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635273724?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:26","pubTimestamp":1778797588,"startTime":"0","endTime":"0","summary":"Valion Bio’s (VBIO) wholly owned subsidiary, Velocity Bioworks, has entered into an exclusive commercial development and license agreement with Lar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valion-bios-velocity-bioworks-licenses-larmorbios-bioscan-nmr-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valion-bios-velocity-bioworks-licenses-larmorbios-bioscan-nmr-platform-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BK4082","VBIO","NMR","BK4552"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635573721","title":"Valion Bio Q1 net loss widens to $6.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635573721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635573721?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:30","pubTimestamp":1778794252,"startTime":"0","endTime":"0","summary":"Valion Bio posted a net loss of USD 6.2 million for quarter ended March 31, 2026, widening from a net loss of USD 1.5 million a year earlier.Operating loss widened to USD 5.63 million as total operating expenses climbed to USD 5.63 million, led by research and development expense of USD 1.85 million and selling, general and administrative costs of USD 3.78 million.Cash and cash equivalents were USD 7.2 million at March 31, 2026, with cash used in operating activities of USD 5.01 million during the quarter.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Valion Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL1LZJGW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635260877","title":"BRIEF-Valion Bio Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635260877","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635260877?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:52","pubTimestamp":1778791970,"startTime":"0","endTime":"0","summary":"BRIEF-Valion Bio Reports First Quarter 2026 Financial ResultsMay 14 (Reuters) - Valion Bio Inc VBIO.O:VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTSVALION BIO INC - Q1 2026 NET LOSS $2.23 PER","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA8JZZ6N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","VBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723211","title":"Valion Bio Q1 EPS $(2.23) Up From $(2.52) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723211","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723211?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:08","pubTimestamp":1778789328,"startTime":"0","endTime":"0","summary":"Valion Bio (NASDAQ:VBIO) reported quarterly losses of $(2.23) per share. This is a 11.51 percent increase over losses of $(2.52) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52579929/valion-bio-q1-eps-2-23-up-from-2-52-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Valion Bio Q1 EPS $(2.23) Up From $(2.52) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTEC","NVIW.SI","NDX","TECS","GPIQ","QQQE","TQQQ","SQQQ","QQQM","IYW",".IXIC","QQQ","QQQJ","PSQ","QYLG","QDTE","QLD","MNQmain","JEPQ","TQQY","NQmain","VBIO","QQQY","QQQA","QID","ONEQ","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/VBIO\",params:#limit:6,delay:false,,,undefined,":[]}}